Program Details
Information about medical programs provided by each healthcare institution, including treatment details, schedules, etc.,
Selective Intra-arterial Chemotherapy Combined with Proton Beam Therapy【 Chubu International Medical Center】
By combining selective intra-arterial chemotherapy with highly precise proton beam therapy, we provide intensive treatment for head and neck cancers.
Our specialist physicians, who have extensive experience with one of the world’s largest case volumes, deliver treatment with a strong emphasis on safety and precision.
By combining selective intra-arterial chemotherapy with highly precise proton beam therapy, we provide intensive and effective treatment for head and neck cancers.
Our physicians have been continuously performing intra-arterial chemotherapy via the superficial temporal artery for many years and possess one of the world’s largest accumulations of cases and extensive clinical experience.
In addition, by using a U.S.-made proton therapy system with world-class precision, we achieve highly accurate and safe irradiation.
The treatment period generally lasts approximately 2 to 3 months.
In many cases, imaging examinations at the completion of treatment confirm tumor disappearance or reduction.
- Providing Medical Institution
-
Social Medical Corporation Koseikai, Chubu International Medical Center
〒505-8510https://cjimc-hp.jp/lang/en
1-1 Kenko-no-machi, Minokamo City- Specialty
- Non-surgical cancer treatments (head and neck cancer, liver cancer, pancreatic cancer, early-stage lung cancer, and locally advanced lung cancer), as well as non-surgical treatment for essential tremor and Parkinson’s disease.
- Eligibility Criteria/Exclusions for Treatment
- Medical Information Required for Eligibility Assessment
Medical certificate
DICOM data
Patient information sheet
Others: Application form for eligibility assessment (designated by our hospital)
- Remarks
- Eligible Diseases / Conditions
Head and neck cancers, advanced oral cancers (tongue cancer)
Department / Physician in Charge
Proton Therapy Cancer Center
Director: Dr. Nobukazu Fuwa